TLR4 and inflammatory bowel disease: In contrast, several strategies based on TLR4 blocking show promising results in the context of epithelial restoration in IBD (not in the case of necrotizing enterocolitis), while constitutively activated TLR4 predisposes for DSS-colitis and colitis-induced neoplasia (236–238).